SJ33

Montana SJ33 requests an interim study on the prescription drug supply chain, pharmacy sustainability, and affordability impacts.

Montana SJ33 directs the Legislative Council to conduct an interim study on the prescription drug supply chain, focusing on stakeholder roles, relationships, and decision-making authority. The study will examine pharmacy operations, prescription drug affordability, and patient access, using aggregated or publicly available data. It will also identify factors contributing to pharmacy openings and closures, explore strategies to reduce patient costs, and assess best practices from other states.